Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Loading
Home›
Research›
Investment Firms›
Pittsburgh Life Sciences Greenhouse
AddedFeb 13, 2024
UpdatedJun 28, 2026
Pittsburgh Life Sciences Greenhouse

Pittsburgh Life Sciences Greenhouse

Operating

Pittsburgh-based PLSG, a venture capital firm investing in biotech, healthcare IT, and medical devices.

Location
Pittsburgh, PA, US
Founded
2001
Firm
Compare
Portfolio
Employees
Website

Investments

Forest Devices
Forest Devices
Seed

Total Raised

$3.7M

Rounds

14

Pre-SeedJune 2020
Debt$550kApril 2017
Neuro Kinetics
Neuro Kinetics

Total Raised

$1.3M

Rounds

3

Series Unknown$155kJune 2019
Clinical Platform
Clinical Platform

Total Raised

$250k

Rounds

4

Seed$90kJune 2019
Convertible Note$45kDecember 2017
Ariel Precision Medicine
Ariel Precision Medicine

Total Raised

$2.7M

Rounds

7

Convertible Note$2.5MMay 2017
Better Body Image
Better Body Image

Total Raised

$305k

Rounds

2

Seed$305kMarch 2016
Medrobotics
Medrobotics

Total Raised

$206.5M

Rounds

14

Series G$25MNovember 2015
Series C$11.7MNovember 2011
Series A$11.6MSeptember 2009
Complexa
Complexa
Public

Total Raised

$86.9M

Rounds

8

Series A$200kOctober 2013
Series A$3.6MJune 2012
ClearCount Medical Solutions
ClearCount Medical Solutions

Total Raised

$19.7M

Rounds

10

Debt Financing$300kOctober 2012
Quantum OPS
Quantum OPS

Total Raised

$1.1M

Rounds

2

Series A$1.1MJune 2012
Pre-Seed$50kMay 2011
Rinovum Women's Health
Rinovum Women's Health

Total Raised

$29.7M

Rounds

6

Series Unknown$475kNovember 2010
Starr Life Sciences
Starr Life Sciences

Total Raised

$4M

Rounds

5

Series UnknownOctober 2010
NeuroInterventional Therapeutics
NeuroInterventional Therapeutics
Acquired

Total Raised

$85k

Rounds

2

SeedJune 2010
Celsense
Celsense

Total Raised

$3.9M

Rounds

10

Debt Financing$150kApril 2010
Saladax Biomedical
Saladax Biomedical

Total Raised

$54.9M

Rounds

9

Series C$8.4MMarch 2010
Series A$3.6MAugust 2008
ThermalTherapeutic Systems
ThermalTherapeutic Systems
Public

Total Raised

$3.5M

Rounds

2

Series A$2.7MDecember 2009
Lipella Pharmaceuticals
Lipella Pharmaceuticals
Public

Total Raised

$6.6M

Rounds

7

Seed$240kApril 2008
Crystalplex
Crystalplex

Total Raised

$3.2M

Rounds

7

Seed$150kNovember 2007
Applied Isotope Technologies
Applied Isotope Technologies

Total Raised

$1.4M

Rounds

3

Seed$150kNovember 2007